- [Resource Hub](/)
- [Resource](/?resource-type=poster#library)
- Neoadjuvant botensilimab plus balstilimab (BOT/BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial

# Neoadjuvant botensilimab plus balstilimab (BOT/BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial

In the neoadjuvant NEST-1 colorectal cancer trial, RareCyte’s Orion platform imaged a 13-marker immune-oncology panel on paired pre- and post-treatment tissue, mapping the shift in the tumor immune microenvironment after immunotherapy.

Presented by Weill Cornell Medicine.

Read or download to see:

- RareCyte’s Orion instrument imaged all 13 markers of an immune-oncology panel on a single paraffin-embedded slide at 20X. Colon and rectal cancer tissue was stained for the full panel and scanned simultaneously, and paired pre-treatment and post-treatment images resolved the tumor immune microenvironment before and after therapy.

- The tumor immune microenvironment shifted toward an immune-active state after therapy. Across markers including CD4, CD8, CD20, CD68 and FOXP3, post-treatment resections showed increased T cell infiltration, T-regulatory cell depletion, and dendritic-cell and myeloid repolarization relative to matched pre-treatment biopsies.

- The NEST-1 trial reported deep pathologic responses in both colorectal cancer subtypes. Investigators found that 6 of 9 patients with MMR-proficient (MSS) tumors had at least 50% pathologic tumor reduction and all 3 patients with MMR-deficient (MSI-High) tumors had major pathologic responses of at least 90%, the investigational neoadjuvant outcomes the Orion immune analysis was carried out to help explain.

[Download poster](https://cdn.sanity.io/files/s3p6uqps/production/bbbfc64e7abf904c60d82b78a71d022349172b2e.pdf)

Your browser doesn’t support embedded PDFs.
[Download the poster](https://cdn.sanity.io/files/s3p6uqps/production/bbbfc64e7abf904c60d82b78a71d022349172b2e.pdf) to view it.

[Back to all resources](/#library)
## Related resources
[Blog](/resources/multiplex-if-choosing-right-technology/) Orion 2026
### Understanding Multiplex Immunofluorescence: Choosing the Right Technology for Discovery, Biomarker Development, and Clinical Research
[Read Blog](/resources/multiplex-if-choosing-right-technology/) [Blog](/resources/biopharma-high-plex-spatial-proteomics-clinical/) Orion 2026
### Four Ways Biopharma Programs Are Using High-Plex Spatial Proteomics in Clinical Development
[Read Blog](/resources/biopharma-high-plex-spatial-proteomics-clinical/) [Webinar](https://www.youtube.com/watch?v=-TU4dRAxydE) Orion 2026
### Inside Orion™ HT: The High-Throughput Spatial Proteomics Platform Built for Biomarker-Driven Clinical Research
[Watch Webinar](https://www.youtube.com/watch?v=-TU4dRAxydE) [Blog](/resources/spatial-proteomics-clinical-research-platform/) Orion 2026
### Spatial Proteomics for Clinical Research: A Platform Perspective
[Read Blog](/resources/spatial-proteomics-clinical-research-platform/) [Video](https://www.youtube.com/watch?v=BBtWzia2sts) Orion 2026
### Dr. Kevin Byrd on identifying the minimal signature needed for clinical trials
[Watch Video](https://www.youtube.com/watch?v=BBtWzia2sts) [Video](https://www.youtube.com/watch?v=07vUECRJ1Mk) Orion 2026
### Dr. Peter Sorger on How His Team Uses Orion™ for Both Discovery and Clinical Applications
[Watch Video](https://www.youtube.com/watch?v=07vUECRJ1Mk) [Video](https://www.youtube.com/watch?v=2nT5Y7rtM9Q) Orion 2026
### How can spatial proteomics be implemented in clinical research settings?
[Watch Video](https://www.youtube.com/watch?v=2nT5Y7rtM9Q) [Webinar](https://rarecyte.com/webinar-spatial-biomarker-panels-for-clinical-trials.html) Orion 2026
### Spatial Biomarker Panels for Clinical Trials
[Watch Webinar](https://rarecyte.com/webinar-spatial-biomarker-panels-for-clinical-trials.html) [Blog](/resources/orion-multiplex-if-diagnostic-pathology/) Orion 2025
### Orion: The Power of Multiplex IF Imaging in Research Diagnostic Pathology
[Read Blog](/resources/orion-multiplex-if-diagnostic-pathology/) [Webinar](https://www.youtube.com/watch?v=lNY-31npm6M) Orion 2025
### Bridging the Discovery-to-Translational Gap in Spatial Biology
[Watch Webinar](https://www.youtube.com/watch?v=lNY-31npm6M) [Blog](/resources/spatial-transcriptomics-to-protein-profiling/) Orion 2025
### The Path to Clinical Relevance: Moving from Spatial Transcriptomics to Protein Profiling
[Read Blog](/resources/spatial-transcriptomics-to-protein-profiling/) [Poster](https://cdn.sanity.io/files/s3p6uqps/production/c9e7039c1a1a3fde2a07116c56f403b2b8d825a1.pdf) Orion 2025
### Novel Digital Pathology Algorithms to Explore the Role of Tumor Microenvironment in Next Generation Immuno-oncology Clinical Trials Utilizing 17-plex Fluorescent Immunohistochemistry
[Download Poster](https://cdn.sanity.io/files/s3p6uqps/production/c9e7039c1a1a3fde2a07116c56f403b2b8d825a1.pdf)